A retrospective study to assess treatment-related changes in neuroendocrine tumors as assessed by textural features derived from 68Ga-DOTATOC PET/MRI with simultaneous acquisition of apparent diffusion coefficient
Latest Information Update: 01 Feb 2021
At a glance
- Drugs Gallium 68-DOTATOC (Primary)
- Indications Neuroendocrine tumours
- Focus Diagnostic use
Most Recent Events
- 01 Feb 2021 New trial record